Clinical trials recruiting for End Stage Renal Disease on Dialysis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Empagliflozin 25 MG | 2 |
| AP306 100 mg TID | 1 |
| AP306 125 mg BID | 1 |
| AP306 125 mg TID | 1 |
| AP306 150 mg BID | 1 |
| AP306 75 mg BID | 1 |
| AP306 75 mg TID | 1 |
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Georgia | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Nevada | 1 |
| New Mexico | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
- EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
- Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
- Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
Related conditions
Trials recruiting for End Stage Renal Disease on Dialysis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for End Stage Renal Disease on Dialysis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.